U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07573449) titled 'How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants' on April 30.
Brief Summary: The purpose of this study is to determine the absorption, metabolism and excretion of [14C]-JNT-517 and to characterize and determine the metabolites present in plasma, urine, and feces in healthy male participants following a single oral administration.
Study Start Date: Jan. 22, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: [14C]-JNT-517
Suspension
Recruitment Status: COMPLETED
Sponsor: Otsuka Pharmaceutical Development & Commercializatio...